Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
An assessment of current practices in the treatment of hidradenitis suppurativa: the rise of biologic therapy
By
- AMS
posted
Sep 24, 2020 08:25 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
- AMS
Added Jun 19, 2020
Blog Entry
Management of adolescents with hidradenitis suppurativa
- AMS
Added Jan 24, 2020
Blog Entry
Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review
- AMS
Added Apr 21, 2020
Blog Entry
Seven years-experience of adalimumab therapy for Hidradenitis Suppurativa in a real-life dermatologic setting
- AMS
Added Oct 22, 2021
Blog Entry
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy
- AMS
Added May 25, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic